LeonaBio (LONA) Gains from Investment Securities (2019 - 2026)

LeonaBio (LONA) has 8 years of Gains from Investment Securities data on file, last reported at $16.3 million in Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at $16.3 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $16.3 million (changed N/A YoY), and the FY2025 annual result was $1.2 million, up 25.35% from the prior year.
• Gains from Investment Securities improved to $16.3 million in Q1 2026 per LONA's latest filing, from $1.2 million in the prior quarter.
• Over five years, Gains from Investment Securities peaked at $16.3 million in Q1 2026 and troughed at $39216.0 in Q1 2024.
• A 5-year average of $3.3 million and a median of $2.2 million in 2025 frame the typical range for Gains from Investment Securities.
• The sharpest annual moves came in 2022 and 2024: Gains from Investment Securities surged 82641.54% in 2022, then slumped 98.1% in 2024.
• A 5-year view of Gains from Investment Securities shows it stood at $4.3 million in 2022, then plunged by 85.38% to $629899.0 in 2023, then surged by 549.12% to $4.1 million in 2024, then slumped by 70.34% to $1.2 million in 2025, then jumped by 1245.53% to $16.3 million in 2026.
• Business Quant data shows LONA's Gains from Investment Securities at $16.3 million in Q1 2026, $1.2 million in Q3 2025, and $2.2 million in Q2 2025.